XML 23 R16.htm IDEA: XBRL DOCUMENT v3.26.3
Equity
9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
Equity

Note 8 – Equity

Authorized Equity

The Company is authorized to issue up to 100,000,000 shares of common stock and 10,000,000 shares of preferred stock. Holders of the Company’s common stock are entitled to receive dividends when authorized by the Company’s Board of Directors.

Reverse Stock Split

On July 9, 2026, the Company effected a 1-for-10 reverse stock split of its common stock, par value $0.01 per share. The common stock began trading on a split-adjusted basis on The Nasdaq Capital Market on July 10, 2026. The number of authorized shares did not change. Outstanding warrants, restricted stock, restricted stock units and similar securities were adjusted proportionately. Each publicly traded warrant became exercisable for 0.10 shares of common stock, and the exercise price increased from $10.00 to $100.00 per share. The exchange ratios for the Operating Partnership’s Series A, Series B-1 and Series B-2 Preferred Units were also adjusted. All share and per-share amounts in these condensed consolidated financial statements have been retroactively adjusted for all periods presented. Operating Partnership units that may be exchanged for common stock are described in Note 7.

Issuance of Equity Securities

Silverback Convertible Note

On February 10, 2026, the Company entered into an Amended and Restated Convertible Note (the "First Amended Note") in the principal amount of $551,437 with Silverback Capital Corporation (the "Noteholder"). The First Amended Note amends and restates that certain Secured Promissory Note, dated April 25, 2025, in the original principal amount of $1,000,000 originally issued to Brown Family Enterprises LLC in exchange for a loan to the Company. The Original Note was sold and assigned to the Noteholder on February 10, 2026 and amended by the Company and the Noteholder on such date. The First Amended Note amended and restated the Original Note by changing the maturity date to February 10, 2027 and changing the interest rate to 9% per annum simple interest. The First Amended Note was convertible into shares of Company common stock ("Conversion Shares"), subject to customary beneficial ownership limitations, at a conversion price of 80% of the "Market Price" (as defined in the First Amended Note) of the Company's common stock at the time of conversion. On February 24, 2026, the First Amended Note was further amended and restated by a second Amended and Restated Convertible Note (the "Second Amended Note"), which amended the First Amended Note by (i) changing the maturity date to February 24, 2027, (ii) providing that the conversion price shall not be less than a floor of $0.10 per share, and (iii) providing that the Second Amended Note may not be converted into a number of shares of Company common stock that exceeds 19.9% of the outstanding shares of Company common stock on the date of the Second Amended Note unless the Company obtains stockholder approval in accordance with the applicable rules of the Nasdaq Stock Market. The Company has determined that the Second Amended Note will be settled entirely through the issuance of shares of common stock, which have been reserved for conversion and are considered issued but not yet outstanding until delivered to the Noteholder. During the nine months ended September 30, 2026, the Noteholder converted an aggregate of $256,397 of principal and accrued interest into 105,393 Conversion Shares, of which 49,693 shares were delivered during the three months ended March 31, 2026 and 55,700 shares were delivered during the three

months ended June 30, 2026, reducing the outstanding balance of the Second Amended Note to $295,039 as of September 30, 2026. As the Second Amended Note is classified as an equity instrument, no interest expense has been recognized in connection with the Second Amended Note during the nine months ended September 30, 2026, and no liability has been recorded on the Company's consolidated balance sheet in connection with the note.

June 2026 Public Offering

On June 1, 2026, the Company completed a public offering of common stock and Common Warrants at $2.10 per share. Purchasers whose ownership would exceed 4.99% (or 9.99% at their election) could instead receive Pre-Funded Warrants, exercisable at $0.001 per share. Each share or Pre-Funded Warrant carried one Common Warrant. Purchasers acquired 2,205,000 Pre-Funded Warrants and 177,500 shares, with 2,382,500 Common Warrants, for gross proceeds of $5,001,060. After the placement agent fee of 7.0% and $85,000 of expenses, the Company received net proceeds of $4,565,833.

The Common Warrants provided that a reverse split within two years of issuance would reset the exercise price to the lowest five-day volume-weighted average price around the event, subject to a floor of $0.562 per share, with the share count increasing proportionately. As a result of the Reverse Stock Split, the exercise price was reset from $2.10 to $1.17, and the shares issuable increased from 2,382,500 to 4,276,282.

Warrant Inducement

On September 18, 2026, the Company entered into an inducement agreement with a holder of the Common Warrants. The holder exercised warrants for 4,074,359 shares for cash at a reduced price of $1.05 per share, down from $1.17. The transaction closed on September 21, 2026, for gross proceeds of $4,278,077. In return, the Company agreed to issue new unregistered five-year warrants for up to 8,148,718 shares at $1.05 per share (the “New Warrants”), exercisable on stockholder approval and expiring five years after that date.

Related-Party Debt Conversion

On July 24, 2026, the Operating Partnership, the Company and the David E. Sobelman Revocable Trust, of which the Company's Chief Executive Officer is trustee, entered into a Debt Conversion Agreement pursuant to which $120,000 of outstanding debt owed by the Operating Partnership to the Sobelman Trust was converted into 162,163 shares of the Company's common stock, at a conversion price of $0.74 per share, the Nasdaq Official Closing Price of the common stock on July 23, 2026. The converted portion of the debt was deemed paid in full and extinguished upon conversion. See Note 10 - Related Party Transactions for further discussion.

Warrants

Private Placement Warrants

The 5,000 warrants issued April 25, 2019 at $200.00 per share expired April 25, 2026. The 5,000 warrants issued November 13, 2020 on the same terms remain outstanding and expire November 13, 2027.

Investor and Representative Warrants

The 16,650 Investor Warrants issued in September 2021 ($100.00 per share) expired September 8 and September 30, 2026, and the 1,499 Representative Warrants issued to Maxim Group LLC ($125.00 per share) expired September 2, 2026.

Representative Warrants

In addition, the Company issued to Maxim Group LLC (or its designee) warrants to purchase an aggregate of 1,499 shares of common stock, which is equal to an aggregate of 9% of the number of shares of common stock sold in the Public Offering (the “Representative’s Warrants”). The Representative’s Warrants had an exercise price of $125.00, could be exercised on a cashless basis, became exercisable six months following the closing date, and expired on September 2, 2026.

Pre-Funded Warrants and Common Warrants — June 2026 Offering

The Pre-Funded Warrants ($0.001 per share) do not expire until exercised in full. The Common Warrants, after the reset, are exercisable for 4,074,359 shares at $1.17, expire June 1, 2031, and may be exercised cashless if no effective registration statement is available. During the nine months ended September 30, 2026, all Pre-Funded Warrants and 4,074,359 Common Warrants were exercised, leaving zero Common Warrants outstanding.

New Warrants

8,148,718 warrants at $1.05 per share, as described under Warrant Inducement. The New Warrants are exercisable only upon stockholder approval and expire five years after that date.

The Company has 8,148,718 and 81,936 warrants outstanding and exercisable as of September 30, 2026 and 2025, respectively, as summarized below.

 

 

As of September 30,

 

Issue Date

2026

 

September 21, 2026 at an exercise price of $1.05

 

8,148,718

 

 

 

8,148,718

 

 

 

Warrants

 

 

Weighted Average Price

 

 

Weighted Average Remaining Life

 

As of December 31, 2025

 

76,946

 

 

$

9.97

 

 

 

2.8

 

Issued

 

12,749,593

 

 

 

-

 

 

 

-

 

Exercised

 

(4,591,091

)

 

 

-

 

 

 

-

 

Expired

 

(86,730

)

 

 

-

 

 

 

-

 

As of September 30, 2026

 

8,148,718

 

 

$

1.05

 

 

 

3.3

 

 

 

 

 

 

 

 

 

 

Warrants exercisable

 

8,148,718

 

 

$

1.05

 

 

 

3.3

 

 

 

 

 

 

 

 

 

 

 

Warrants

 

 

Weighted Average Price

 

 

Weighted Average Remaining Life

 

As of December 31, 2024

 

81,936

 

 

$

11.61

 

 

 

2.5

 

Exercised

 

-

 

 

 

-

 

 

 

-

 

As of September 30, 2025

 

81,936

 

 

$

11.61

 

 

 

2.5

 

 

 

 

 

 

 

 

 

 

Warrants exercisable

 

81,936

 

 

$

11.61

 

 

 

2.5

 

 

There was no intrinsic value for the warrants as of September 30, 2026 or 2025.

Stock Compensation

 

Generation Income Properties, Inc. 2020 Omnibus Incentive Plan

In connection with the Public Offering, the Company's Board of Directors adopted and stockholders approved, the Generation Income Properties, Inc. 2020 Omnibus Incentive Plan (the “Omnibus Incentive Plan”), which became effective upon the completion of the Public Offering. The Omnibus Incentive Plan reserves 200,000 shares of common stock for stock options, stock appreciation rights, performance shares, performance units, shares of common stock, restricted stock, restricted stock units, cash incentive awards, dividend equivalent units, or any other type of award permitted under the Omnibus Incentive Plan. As of September 30, 2026 and 2025, 220,162 shares had been granted under the Omnibus Incentive Plan.

 

Restricted Common Shares issued to the Board and Employees

The following is a summary of restricted shares for the nine months ended September 30, 2026 and 2025:

 

 

2026

 

 

2025

 

Number of Shares Outstanding at beginning of period

 

18,732

 

 

 

6,132

 

Restricted Shares Issued

 

165

 

 

 

-

 

Restricted Shares Vested

 

(2,171

)

 

 

-

 

Number of Shares Outstanding at end of period

 

16,726

 

 

 

6,132

 

 

The Company recorded stock based compensation expense of $90,000 and $345,000 and $0 and $0, during the three and nine months ended September 30, 2026 and 2025, respectively.

 

Cash Distributions

The Company announced that its Board of Directors determined to suspend the Company’s regular dividend, commencing with the monthly dividends that would have been paid in July 2024.

The issuance of future distributions will be determined by the Company's board of directors based on the Company's financial condition and such other factors as the Company's board of directors deems relevant. The Company has not established a minimum distribution, and the Company's charter does not require that the Company issue distributions to its stockholders other than as necessary to meet REIT qualification standards.